Picture of Biotech Growth Trust logo

BIOG — Biotech Growth Trust Share Price

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedSmall Cap

Momentum

Relative Strength (%)
1m-9.77%
3m-8.22%
6m-33.72%
1yr-41.43%
Volume Change (%)
10d/3m+11.78%
Price vs... (%)
52w High-44.46%
50d MA-7.48%
200d MA-24.25%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-4.98%
Return on Equity-5.01%
Operating Margin87.02%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202231st Mar 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Biotech Growth Trust EPS forecast chart

Profile Summary

The Biotech Growth Trust PLC is a United Kingdom-based investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company invests approximately 15% in aggregate of the value of its gross assets in other closed-ended investment companies, including investment trusts listed on the London Stock Exchange. The Company invests approximately 15% of the value of its gross assets in any one individual stock at the time of acquisition. The Company's portfolio manager is OrbiMed Capital LLC. Its alternative investment fund manager is Frostrow Capital LLP.

Directors

Last Annual
March 31st, 2021
Last Interim
September 30th, 2021
Incorporated
May 20th, 1997
Public Since
June 23rd, 1997
No. of Employees
0
Sector
Collective Investments
Industry
Financials
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
41,158,682

BIOG Share Price Performance

Latest News for BIOG

Upcoming Events for BIOG

Full Year 2022 Biotech Growth Trust PLC Earnings Release

Biotech Growth Trust PLC Annual Shareholders Meeting

Half Year 2023 Biotech Growth Trust PLC Earnings Release

Similar to BIOG

FAQ

Or unlock with your email

Or unlock with your email